Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Gains from Investment Securities (2019 - 2025)

aTYR PHARMA's Gains from Investment Securities history spans 6 years, with the latest figure at $139000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 137.98% year-over-year to $139000.0; the TTM value through Dec 2025 reached $539000.0, up 17866.67%, while the annual FY2025 figure was $539000.0, 17866.67% up from the prior year.
  • Gains from Investment Securities reached $139000.0 in Q4 2025 per ATYR's latest filing, up from $136000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.0 million in Q1 2023 to a low of -$1.0 million in Q2 2023.
  • Average Gains from Investment Securities over 4 years is $42666.7, with a median of $125000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: soared 1071.91% in 2023, then plummeted 5128.57% in 2024.
  • A 4-year view of Gains from Investment Securities shows it stood at -$708000.0 in 2022, then skyrocketed by 99.01% to -$7000.0 in 2023, then tumbled by 5128.57% to -$366000.0 in 2024, then surged by 137.98% to $139000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Gains from Investment Securities are $139000.0 (Q4 2025), $136000.0 (Q3 2025), and $133000.0 (Q2 2025).